Filing Details

Accession Number:
0000950170-24-057456
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-10 07:30:19
Reporting Period:
2024-05-08
Accepted Time:
2024-05-10 07:30:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1095981 Plus Therapeutics Inc. PSTV Surgical & Medical Instruments & Apparatus (3841) 330827593
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1802687 Macintyre Hugh John Andrew Sims C/O Plus Therapeutics Inc.
4200 Marathon Boulevard, Suite 200
Austin TX 78756
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-08 4,902 $2.04 5,717 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Warrants (Right to buy) Acquisiton 2024-05-08 9,804 $0.00 9,804 $1.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,804 2024-05-08 No 4 A Direct
Footnotes
  1. The expiration date for 4,902 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,902 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.
  2. Half of the warrants are Series A warrants and the other half are Series B warrants.